The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis
Open accessAbstract
Extracorporeal albumin dialysis (ECAD) may improve severe hepatic encephalopathy (HE) in patients with advanced cirrhosis via the removal of protein or non–protein-bound toxins. A prospective, randomized, controlled, multicenter trial of the efficacy, safety, and tolerability of ECAD using molecular adsorbent recirculating system (MARS) was conducted in such patients. Patients were randomized to ECAD and standard medical therapy (SMT) or SMT alone. ECAD was provided daily for 6 hours for 5 days or until the patient had a 2-grade improvement in HE. HE grades (West Haven criteria) were evaluated every 12 hours using a scoring algorithm. The primary endpoint was the difference in improvement proportion of HE between the 2 groups. A total of 70 subjects [median age, 53; 56% male; 56% HE grade 3; 44% HE grade 4; median model for end-stage liver disease (MELD) 32 (11–50) and CPT 13 (10–15)] were enrolled in 8 tertiary centers. Patients were randomized to ECAD + SMT (n = 39) or SMT alone (n = 31). Groups were matched in demographics and clinical variables. The improvement proportion of HE was higher in ECAD (mean, 34%; median, 30%) versus the SMT group (mean, 18.9%; median, 0%) ( P = 0.044) and was reached faster and more frequently than in the SMT group ( P = 0.045). Subjects receiving ECAD tolerated treatment well with no unexpected adverse events. Conclusion: The use of ECAD may be associated with an earlier and more frequent improvement of HE (grade 3/4). Because this 5-day study was not designed to examine the impact of MARS on survival, a full assessment of the role of albumin dialysis awaits the results of additional controlled trials. (Hepatology 2007.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Understanding Psychological Assessment · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,731
Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., & Blei, A. T. (2002) · Hepatology · doi:10.1053/jhep.2002.31250 · Cited by 2,043
Self-citationThe hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317
Comparative reliability and validity of chronic pain intensity measures.
Jensen, M. P., Turner, J. A., Romano, J. M., & Fisher, L. D. (1999) · Pain · doi:10.1016/s0304-3959(99)00101-3 · Cited by 1,247
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L. B., & Levy, L. L. (1977) · PubMed · Cited by 641
Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L., & Levy, L. L. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80135-2 · Cited by 628
Stange, Mitzner, Risler, Erley, Lauchart, Goehl, Klammt, S., Peszynski, Freytag, Hickstein, et al. (1999) · Artificial Organs · doi:10.1046/j.1525-1594.1999.06122.x · Cited by 604
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
Bustamante, J., Rimola, A., Ventura, P.-J., Navasa, M., Cirera, I., Reggiardo, V., & Rodés, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80144-5 · Cited by 567
Treatment of Hepatic Encephalopathy
Riordan, S. M., & Williams, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370707 · Cited by 489
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
Heemann, U. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00102-7 · Cited by 429
Kjaergard, L. L., Liu, J., Als-Nielsen, B., & Gluud, C. (2003) · JAMA · doi:10.1001/jama.289.2.217 · Cited by 379
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
Als-Nielsen, B., Gluud, L. L., & Gluud, C. (2004) · BMJ · doi:10.1136/bmj.38048.506134.ee · Cited by 371
Wehler, M., Kokoska, J., Reulbach, U., Hahn, E. G., & Strauss, R. (2001) · Hepatology · doi:10.1053/jhep.2001.26522 · Cited by 251
Schmidt, L. E., Wang, L. P., Hansen, B. A., & Larsen, F. S. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50051 · Cited by 231
Self-citationDialysis against a Recycled Albumin Solution Enables the Removal of Albumin‐Bound Toxins
Stange, J., Ramlow, W., Mitzner, S., Schmidt, R., & Klinkmann, H. (1993) · Artificial Organs · doi:10.1111/j.1525-1594.1993.tb00635.x · Cited by 219
Self-citationStange, J., Hassanein, T. I., Mehta, R., Mitzner, S. R., & Bartlett, R. H. (2002) · Artificial Organs · doi:10.1046/j.1525-1594.2002.06822.x · Cited by 206
Self-citationThe pathophysiological basis of acute‐on‐chronic liver failure
Sen, S., Williams, R., Jalan, R., Sen, S., Williams, R., & Jalan, R. (2002) · Liver · doi:10.1034/j.1600-0676.2002.00001.x · Cited by 188
Khuroo, M. S., Khuroo, M. S., & Farahat, K. L. C. (2004) · Liver Transplantation · doi:10.1002/lt.20139 · Cited by 176
Outcome of Hospital Care of Liver Disease Associated With Hepatitis C in the United States
Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, R. G., & Dickson, R. E. (2001) · Hepatology · doi:10.1053/jhep.2001.20798 · Cited by 106
Doria, C., Mandalà, L., Smith, J. D., Caruana, G., Scott, V. L., Gruttadauria, S., Magnone, M., & Marino, I. R. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00172.x · Cited by 51
Butterworth, R. F. (2003) · Liver International · doi:10.1034/j.1478-3231.23.s.3.1.x · Cited by 50
Cited by
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party., Sarin, S. K., Choudhury, A., Sharma, M. K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A. S., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09946-3 · Cited by 884
Acute-on chronic liver failure
Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., Arroyo, V., & Kamath, P. S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.026 · Cited by 646
Acute-on-chronic liver failure: an update
Hernaez, R., Solà, E., Moreau, R., & Ginès, P. (2017) · Gut · doi:10.1136/gutjnl-2016-312670 · Cited by 605
Martín–Llahí, M., Pépin, M., Guevara, M., Díaz, F., Torre, A., Monescillo, A., Soriano, G., Terra, C., Fábrega, E., Arroyo, V., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.024 · Cited by 601
Metadata
- Authors
- Hassanein, T. I., Tofteng, F., Brown, R. S., McGuire, B., Lynch, P., Mehta, R., Larsen, F. S., Gornbein, J., Stange, J., & Blei, A. T.
- Venue
- Hepatology
- Published
- 2007-12
- Volume
- 46
- Issue
- 6
- Pages
- 1853-1862
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2072994640
- Cited by
- 407
- References
- 22
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.